Autifony Initiates Phase I Study for AUT00063 for Hearing Loss and Tinnitus Treatment

News   Jun 10, 2013

 
Autifony Initiates Phase I Study for AUT00063 for Hearing Loss and Tinnitus Treatment
 
 
 
FURTHER INFORMATION
 

This content appears on:

Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT